Back to Search
WAYNE DANKNER, MD
MD
Specialist
NPI: 1295006450Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
200001477(NC)
Research & Publications (20)
Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment.
PMID 19617848·J Acquir Immune Defic Syndr·2009
3-trial
Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era.
PMID 19188649·Arch Pediatr Adolesc Med·2009
4-observational
The Pediatric AIDS Severity Score (PASS): a multidimensional AIDS-severity adjustment for pediatric HIV infection.
PMID 17003692·J Acquir Immune Defic Syndr·2006
8-other
Simple Pediatric AIDS Severity Score (PASS): a pediatric severity score for resource-limited settings.
PMID 17003691·J Acquir Immune Defic Syndr·2006
8-other
Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.
PMID 16894075·Arch Pediatr Adolesc Med·2006
8-other
Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
PMID 16849662·JAMA·2006
4-observational
Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.
PMID 16362896·J Infect Dis·2006
8-other
GB virus C infection in children with perinatal human immunodeficiency virus infection.
PMID 15876940·Pediatr Infect Dis J·2005
4-observational
The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
PMID 15772172·Pediatrics·2005
3-trial
Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
PMID 15614703·Clin Infect Dis·2005
3-trial
Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocol.
PMID 15466691·Arch Pediatr Adolesc Med·2004
4-observational
A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.
PMID 15120718·Int J Antimicrob Agents·2004
3-trial
Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents.
PMID 14697803·Lancet·2003
4-observational
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial.
PMID 12915819·J Pediatr·2003
3-trial
Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.
PMID 11794218·N Engl J Med·2001
3-trial
Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children.
PMID 11581480·Pediatrics·2001
4-observational
Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.
PMID 11176565·Pediatr Infect Dis J·2001
8-other
Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials Group.
PMID 11069232·J Infect Dis·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2520 MERIDIAN PKWY
DURHAM, NC 27713 - Phone
- (919) 294-5026
Quick Facts
- NPI
- 1295006450
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile